PL1694697T3 - Zlokalizowane na powierzchni polipeptydy campylobacter jejuni - Google Patents

Zlokalizowane na powierzchni polipeptydy campylobacter jejuni

Info

Publication number
PL1694697T3
PL1694697T3 PL04797464T PL04797464T PL1694697T3 PL 1694697 T3 PL1694697 T3 PL 1694697T3 PL 04797464 T PL04797464 T PL 04797464T PL 04797464 T PL04797464 T PL 04797464T PL 1694697 T3 PL1694697 T3 PL 1694697T3
Authority
PL
Poland
Prior art keywords
campylobacter
polypeptides
campylobacter jejuni
located polypeptides
relates
Prior art date
Application number
PL04797464T
Other languages
English (en)
Inventor
Petra Schrotz-King
Crawford Janne Skaarup
Nielsen Pia Nyborg
Tatyana A Prokhorova
Original Assignee
Ace Biosciences As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ace Biosciences As filed Critical Ace Biosciences As
Publication of PL1694697T3 publication Critical patent/PL1694697T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/105Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL04797464T 2003-11-21 2004-11-19 Zlokalizowane na powierzchni polipeptydy campylobacter jejuni PL1694697T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200301726 2003-11-21
US52461703P 2003-11-25 2003-11-25
PCT/DK2004/000803 WO2005049641A2 (en) 2003-11-21 2004-11-19 Surface-located campylobacter jejuni polypeptides
EP04797464A EP1694697B1 (en) 2003-11-21 2004-11-19 Surface-located campylobacter jejuni polypeptides

Publications (1)

Publication Number Publication Date
PL1694697T3 true PL1694697T3 (pl) 2011-05-31

Family

ID=43426113

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04797464T PL1694697T3 (pl) 2003-11-21 2004-11-19 Zlokalizowane na powierzchni polipeptydy campylobacter jejuni

Country Status (14)

Country Link
US (1) US20070178110A1 (pl)
EP (1) EP1694697B1 (pl)
JP (1) JP2008501625A (pl)
KR (1) KR20060129229A (pl)
CN (1) CN1906210A (pl)
AT (1) ATE493431T1 (pl)
AU (1) AU2004291213B2 (pl)
CA (1) CA2546873A1 (pl)
DE (1) DE602004030824D1 (pl)
DK (1) DK1694697T3 (pl)
ES (1) ES2358804T3 (pl)
NO (1) NO20062916L (pl)
PL (1) PL1694697T3 (pl)
WO (1) WO2005049641A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090074774A1 (en) * 2004-06-18 2009-03-19 Elisabeth Bock Fgfr binding peptides
CN101203239B (zh) * 2005-03-31 2014-09-17 莱顿大学医药中心 诊断、预防和治疗分枝杆菌感染和结核疾病的方法和装置
EP2453909A4 (en) 2009-07-16 2013-05-01 Univ Washington State Res Fdn ANTIGENIC COMPOSITIONS AND METHODS FOR INHIBITING BACTERIAL INFECTIONS WITH CAMPYLOBACTER JEJUNI AND USES OF THESE ANTIGENIC COMPOSITIONS
NZ604412A (en) 2010-06-09 2015-01-30 Univ Arkansas Vaccine and methods to reduce campylobacter infection
BR112014018732A8 (pt) * 2012-02-01 2017-07-11 Univ Arizona Composições imunogênicas contra campylobacter e usos das mesmas
US10248758B2 (en) * 2013-02-07 2019-04-02 University Of Washington Through Its Center For Commercialization Self-assembling protein nanostructures
CA2906079C (en) 2013-03-15 2022-08-23 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
KR20190015712A (ko) 2016-05-03 2019-02-14 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법
WO2018140717A1 (en) 2017-01-27 2018-08-02 University Of Florida Research Foundation Incorporated A food safety vaccine to control salmonella enterica and reduce campylobacter in poultry
CN112867541B (zh) * 2018-07-17 2024-08-30 胡默波斯生物医学公司 针对弯曲杆菌物种的抗体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
WO1998043478A1 (en) * 1997-04-01 1998-10-08 Merieux Oravax Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
AU3458299A (en) * 1998-03-31 1999-10-18 United States Of America, As Represented By The Secretary Of Agriculture, The Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
JP2000351735A (ja) * 1999-04-09 2000-12-19 Akzo Nobel Nv カンピロバクターワクチン
CA2296869A1 (en) * 2000-01-24 2001-07-24 Angela Joe A surface-exposed lipoprotein to campylobacter jejuni involved in adherence to hep-2 cells
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms

Also Published As

Publication number Publication date
ES2358804T3 (es) 2011-05-13
CA2546873A1 (en) 2005-06-02
DE602004030824D1 (de) 2011-02-10
KR20060129229A (ko) 2006-12-15
WO2005049641A2 (en) 2005-06-02
CN1906210A (zh) 2007-01-31
HK1097854A1 (en) 2007-07-06
AU2004291213B2 (en) 2011-09-08
DK1694697T3 (da) 2011-04-18
ATE493431T1 (de) 2011-01-15
US20070178110A1 (en) 2007-08-02
WO2005049641A3 (en) 2005-10-20
AU2004291213A1 (en) 2005-06-02
JP2008501625A (ja) 2008-01-24
EP1694697B1 (en) 2010-12-29
NO20062916L (no) 2006-08-21
EP1694697A2 (en) 2006-08-30

Similar Documents

Publication Publication Date Title
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
MXPA02000192A (es) Composiciones y metodos para la terapia y diagnostico de cancer de pulmon.
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
WO2004037999A3 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
WO2001040269A3 (en) Compositions and methods for therapy and diagnosis of breast cancer
WO2001096388A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001096390A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2001034802A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
WO2000060076A3 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
WO2001025272A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
DK1576967T3 (da) Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelse
ATE450547T1 (de) Eml4-alk-fusionsgen
WO2000004149A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU2003253125A8 (en) Cell penetrating peptides
WO2001079286A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
PL1694697T3 (pl) Zlokalizowane na powierzchni polipeptydy campylobacter jejuni
WO2001073027A3 (en) Compositions and methods for therapy and diagnosis of colon cancer
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
WO2007087263A3 (en) Human zip1, zinc and citrate for prostate cancer screening
EP1887082A3 (en) TADG-15: An extracellular serine protease overexpressed in carcinomas
WO2001057207A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2002039885A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2000078960A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2001051513A3 (en) Ovarian tumor-associated sequences
AR029540A1 (es) COMPOSICIONES Y METODOS PARA EL DIAGNoSTICO Y LA TERAPIA DE CA NCER DE PULMoN